Human epididymis protein 4 (HE4), firstly identified and characterized as a human epididymis-specific protein [5], nowadays, has been accepted as a useful biomarker for ovarian cancer or other malignancies [6, 7]. Here, WFDC2 is linked to ovarian carcinoma.